Literature DB >> 15591470

Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease.

Ciro Casanova1, Claudia Cote, Juan P de Torres, Armando Aguirre-Jaime, Jose M Marin, Victor Pinto-Plata, Bartolome R Celli.   

Abstract

Static lung hyperinflation has important clinical consequences in patients with chronic obstructive pulmonary disease. We analyzed the power of lung hyperinflation as measured by the inspiratory capacity-to-total lung capacity ratio (IC/TLC) to predict mortality in a cohort of 689 patients with chronic obstructive pulmonary disease (95% males; FEV(1), 1.17 L) with a mean follow-up of 34 months. We also compared the predictive value of IC/TLC with that of the BODE (body mass index, airflow obstruction, dyspnea, exercise performance) Index. Subjects who died (183; 27%) were older; had lower body mass index, FEV(1), and IC/TLC ratio; walked less in the 6-minute walking distance; and had more dyspnea, a higher BODE Index, and comorbidity (p < 0.001). On the basis of logistic regression analysis, IC/TLC was found to be a good and independent predictor of all-cause and respiratory mortality. On the basis of receiver operating characteristic Type II curves, IC/TLC compared favorably with FEV(1) and predicted mortality independently of the BODE Index. We conclude that IC/TLC is an independent risk factor for mortality in subjects with chronic obstructive pulmonary disease. We propose that this ratio be considered in the assessment of patients with chronic obstructive pulmonary disease.

Entities:  

Mesh:

Year:  2004        PMID: 15591470     DOI: 10.1164/rccm.200407-867OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  108 in total

Review 1.  Alternatives to lung transplantation: lung volume reduction for COPD.

Authors:  Gerard J Criner
Journal:  Clin Chest Med       Date:  2011-06       Impact factor: 2.878

2.  Inspiratory capacity as a preoperative assessment of patients undergoing thoracic surgery.

Authors:  Masaki Matsuo; Naozumi Hashimoto; Noriyasu Usami; Kazuyoshi Imaizumi; Kenji Wakai; Tsutomu Kawabe; Kohei Yokoi; Yoshinori Hasegawa
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-03

3.  Interpretation of pulmonary function test: issues and controversies.

Authors:  Cristine E Berry; Robert A Wise
Journal:  Clin Rev Allergy Immunol       Date:  2009-03-21       Impact factor: 8.667

Review 4.  Role of indacaterol, a once-daily bronchodilator, in chronic obstructive pulmonary disease.

Authors:  Heemesh D Seth; Samir Sultan; Mark H Gotfried
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

Review 5.  The pharmacological approach to the elderly COPD patient.

Authors:  Timothy E Albertson; Michael Schivo; Amir A Zeki; Samuel Louie; Mark E Sutter; Mark Avdalovic; Andrew L Chan
Journal:  Drugs Aging       Date:  2013-07       Impact factor: 3.923

6.  BODE-Index vs HADO-score in chronic obstructive pulmonary disease: Which one to use in general practice?

Authors:  Cristóbal Esteban; José M Quintana; Javier Moraza; Myriam Aburto; Urko Aguirre; José I Aguirregomoscorta; Susana Aizpiri; Luis V Basualdo; Alberto Capelastegui
Journal:  BMC Med       Date:  2010-05-24       Impact factor: 8.775

Review 7.  Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations.

Authors:  Thomas Glaab; Claus Vogelmeier; Roland Buhl
Journal:  Respir Res       Date:  2010-06-17

8.  Longitudinal lung volume changes in patients with chronic obstructive pulmonary disease.

Authors:  Jae Seung Lee; Seon Ok Kim; Joon Beom Seo; Ji-Hyun Lee; Eun Kyung Kim; Tae-Hyung Kim; Woo Jin Kim; Jin Hwa Lee; Sang-Min Lee; Sangyeub Lee; Seong Yong Lim; Tae Rim Shin; Ho Il Yoon; Sei Won Lee; Jin Won Huh; Yeon-Mok Oh; Sang-Do Lee
Journal:  Lung       Date:  2013-05-29       Impact factor: 2.584

Review 9.  Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studies.

Authors:  Marc Miravitlles; Antonio Anzueto
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-05-07

Review 10.  Hyperinflation and its management in COPD.

Authors:  Luis Puente-Maestu; William W Stringer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.